Moderna shares surge after it says experimental mRNA cancer treatment passed key test
Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors.
We haven't written up this one. PBS NewsHour Health has the full story — the link below goes straight to it.